• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[乳腺癌以及上呼吸道和消化道癌的标记指数(作者译)]

[Labelling index in breast cancer and in upper respiratory and digestive tract cancer (author's transl)].

作者信息

Gioanni J, Farges M F, Asin C, Lalanne C M

出版信息

Bull Cancer. 1979;66(5):479-84.

PMID:554672
Abstract

The labelling index (LI) of 96 breast adenocarcinomas and of 43 upper respiratory and digestive tract cancers has been measured. For the two histological groups, the distribution of individual values is found to be log-normal, with a mean value depending on the tumour type. Our data have been compared with other authors results. The dispersion of individual values within a same histological type suggests that the LI is interesting as an individual value depending on the patient and his own cancer. For breast adenocarcinomas the LI values obtained have been separated in two groups depending upon the patient age, the age of 53 has been chosen to separate premenopausal from post-menopausal patients. A test of significance showed that the two corresponding log-normal distributions were different, even at the 0.01 level of significance, a mean LI value thus characterizing each distribution.

摘要

已对96例乳腺腺癌和43例上呼吸道及消化道癌症的标记指数(LI)进行了测量。对于这两个组织学组,发现个体值的分布呈对数正态分布,其平均值取决于肿瘤类型。我们的数据已与其他作者的结果进行了比较。同一组织学类型内个体值的离散性表明,LI作为取决于患者及其自身癌症的个体值很有意义。对于乳腺腺癌,根据患者年龄将获得的LI值分为两组,选择53岁作为区分绝经前和绝经后患者的年龄界限。显著性检验表明,即使在0.01的显著性水平下,两个相应的对数正态分布也是不同的,因此每个分布都有一个平均LI值作为特征。

相似文献

1
[Labelling index in breast cancer and in upper respiratory and digestive tract cancer (author's transl)].[乳腺癌以及上呼吸道和消化道癌的标记指数(作者译)]
Bull Cancer. 1979;66(5):479-84.
2
[Surgical treatment of associated bronchial, upper respiratory and digestive tract cancers].[支气管、上呼吸道及消化道相关癌症的外科治疗]
Rev Laryngol Otol Rhinol (Bord). 1990;111(1):55-8.
3
[Histological aspects and prognostic significance of the regional immune reaction in carcinomas of the upper respiratory and digestive tracts].[上呼吸道和消化道癌区域免疫反应的组织学特征及预后意义]
Ann Otolaryngol Chir Cervicofac. 1987;104(7):501-7.
4
[Tumor regression following local chemotherapy in carcinomas of the upper respiratory and digestive tracts. The viewpoint of the pathologist].[上呼吸道和消化道癌局部化疗后的肿瘤消退。病理学家的观点]
Ann Otolaryngol Chir Cervicofac. 1983;100(8):577-80.
5
[Dermatomyositis as a paraneoplastic manifestation in cancer of the upper respiratory and digestive tracts. Problems of its evolution and treatment].
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol. 1985 Apr-Jun;30(2):107-10.
6
Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast.在绝经前女性乳腺的纤维囊性变和癌中,相对于组织学正常上皮中的有丝分裂,细胞凋亡减少。
J Pathol. 1992 May;167(1):25-32. doi: 10.1002/path.1711670106.
7
[Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].[肺多原发性肿瘤合并其他器官的临床特征及预后——附281例报告]
Ai Zheng. 2006 Jun;25(6):731-5.
8
[Distant metastases of epitheliomas of the upper respiratory and digestive tracts].[上呼吸道和消化道上皮瘤的远处转移]
Rev Laryngol Otol Rhinol (Bord). 1990;111(1):51-3.
9
In vitro thymidine labelling index in primary operable breast cancer.
Eur J Surg Oncol. 1986 Mar;12(1):53-7.
10
[Combination of radiotherapy and chemotherapy in the treatment of upper respiratory and digestive tract carcinomas (author's transl)].
Bull Cancer. 1981;68(2):158-62.